Cheltenham & Gloucester is repricing the rates on its three-year premium fixed rate mortgage and its standard two, three, five and seven-year fixed rate mortgages.Nick Hale, sales director at C&G, says: “Following the increase in the cost of purchasing funds through the money markets it has been necessary for C&G to review its rates and these new products are available from September 5. We are able to maintain our 4.39% two-year premium fixed rate for the time being but this is unlikely to be sustainable for long.”
Mark Riddick, the newly appointed chairman of the Property Information Systems Common Exchange Standard and CEO of SearchFlow, is leading the organisations first annual conference on September 7 and 8 in Stratford-upon-Avon, as chair and facilitator. Riddick was unanimously appointed as PISCES chairman by board members on August 5 2005.The conference is aimed at providing […]
Alliance & Leicester is introducing greater lending flexibility as it moves away from using traditional income multiples to assess how much customers can borrow. This new flexibility is aimed to help more people afford homes that were previously out of their reach and will particularly benefit those with higher disposable incomes and first time buyers.The […]
For more years than I care to remember I have called for less fragmentation in the mortgage industry. I am convinced this can be achieved by a certain measure of unification but without creating a cartel.
From Lee Martin I must have a moan about the service I am getting from Mortgage Express. It is useless – complete and utter garbage. I did a DIP using its online system on July 28 which was referred and two days later I received an email saying it was accepted. I was then unable […]
A major feature of our articles is looking into the Jelf Employee Benefits crystal ball to predict changes and trends that may influence the short and medium term shape of UK employee benefits. By flagging such changes early we aim to provide our followers with the tools to make sensible and informed decisions on their benefits offerings.
News and expert analysis straight to your inboxSign up